Vote Scores

Home / Companies / Adaptive Biotechnologies Corporation / 10 Jun 2025

Meeting · year to 30 June 2025339 filers reporting

Adaptive Biotechnologies Corporation: meeting of 10 Jun 2025

Votes reported on Form N-PX, item by item

339 Form N-PX filers reported votes at the Adaptive Biotechnologies Corporation meeting of 10 Jun 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

1 nominee; 60.5% of reported votes for; 53 filers withheld from or voted against at least one nominee.

202 vote records from 119 filers. 47 of the 118 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

58.8% for0.0% against41.2% other39.8% against management119 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

483 vote records from 337 filers. 13 of the 322 filers that marked the item either way voted against management. 15 filers reported this item without a management mark.

91.4% for3.9% against4.7% other4.0% against management337 filers98.8% for1.1% against0.1% other1.1% against management137,248,504 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

202 vote records from 119 filers. 0 of the 118 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

99.2% for0.0% against0.8% other0.0% against management119 filers100.0% for0.0% against0.0% against management48,414,751 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyAbstain or withhold *ForFor
Franklin TempletonForForFor
InvescoForForFor
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeAbstain or withhold *ForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *ForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialForAgainst *For
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaAbstain or withhold *ForFor
First TrustAbstain or withhold *ForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalAbstain or withhold *ForFor
Brighthouse FundsForForFor
Guggenheim and RydexAbstain or withhold *ForFor
Columbia ThreadneedleForForFor
BNY MellonNo reportForNo report
PrincipalNo reportForNo report
Pacific Life fundsForForFor
Global XForForFor
MFSForForFor
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
DWSAbstain or withhold *ForFor
PIMCONo reportForNo report
AllspringAbstain or withhold *ForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
Lord AbbettAbstain or withhold *ForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Adaptive Biotechnologies Corporation meeting?

339 Form N-PX filers reported votes at the meeting of 10 Jun 2025. On say-on-pay, 13 of 322 voted against management (4.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Adaptive Biotechnologies Corporation on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Adaptive Biotechnologies Corporation

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Adaptive Biotechnologies Corporation with a meeting date within three days of 10 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.